Your browser doesn't support javascript.
loading
Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer.
Shankar, Eswar; Franco, Daniel; Iqbal, Omair; Moreton, Stephen; Kanwal, Rajnee; Gupta, Sanjay.
Affiliation
  • Shankar E; Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  • Franco D; College of Arts and Sciences, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Iqbal O; College of Arts and Sciences, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Moreton S; Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA.
  • Kanwal R; Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  • Gupta S; Department of Urology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA; Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, US
Toxicol Appl Pharmacol ; 404: 115200, 2020 10 01.
Article in En | MEDLINE | ID: mdl-32805266
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Pyridones / Prostatic Neoplasms, Castration-Resistant / Enhancer of Zeste Homolog 2 Protein / Indoles / Antineoplastic Agents Type of study: Guideline Limits: Humans / Male Language: En Journal: Toxicol Appl Pharmacol Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Pyridones / Prostatic Neoplasms, Castration-Resistant / Enhancer of Zeste Homolog 2 Protein / Indoles / Antineoplastic Agents Type of study: Guideline Limits: Humans / Male Language: En Journal: Toxicol Appl Pharmacol Year: 2020 Type: Article Affiliation country: United States